Embarke
Embarke creates audit-oriented research syntheses for medical writers, regulatory teams, and health technology assessment professionals.
What Embarke is
Embarke creates audit-oriented research syntheses for medical writers, regulatory teams, and health technology assessment professionals. Its PRISMA 2020-aligned runs produce a structured report and flow diagram. The Calibrator estimates certainty for each finding against GRADE domains, marking ratings as machine-estimated for human review. Risk-of-bias methods include RoB 2, ROBINS-I, AMSTAR 2, and QUADAS-2, with reviewer overrides for proposed judgments. DOI enrichment through Crossref and Retraction Watch helps reports flag retracted papers and expressions of concern. Exported ZIP files can contain report files, source and model details, prompt hashes, citation exports, and a SHA-256 manifest signature. Saved projects can rerun daily, weekly, or monthly and report citation or retraction-status changes. Embarke is available on the web or as a self-hosted open-source stack deployed on a customer’s Kubernetes infrastructure. The free plan includes three PRISMA-light reviews per month, unlimited Discover answers, Tier-1 sources, watermarked outputs, and no certainty ratings. Pricing is described as a preview, and checkout is not active; prospective users are directed to contact Embarke for early access.
Good
- Generates structured PRISMA-aligned reports and diagrams
- Includes several risk-of-bias methods
- Flags retractions and expressions of concern
- Exports source and model details with reports
- Saved projects can rerun on a schedule
Watch out
- Free plan has three PRISMA-light reviews monthly
- Free outputs are watermarked and lack certainty ratings
- Self-serve checkout is not active
- Synthesis lacks prospective registration and independent dual screening
Who it suits
Embarke is intended for medical writers, regulatory teams, and health technology assessment professionals who need documented research syntheses. Its self-hosted option is for customers deploying on their own Kubernetes infrastructure.
Verdict
Embarke offers synthesis, review tools, and detailed report exports, with paid tiers starting at $39/mo. Its pricing is still a preview, and its AI-assisted process does not include prospective protocol registration or independent dual screening.
Plans and prices
From Embarke's own pricing page, checked 8 Oct 2026.
| Plan | Price | What it gives you |
|---|---|---|
| Free | Free | 3 PRISMA-light reviews per month · unlimited Discover answers · Tier-1 sources only · watermarked outputs · no certainty ratings |
| Plus | $39 a month | Unlimited PRISMA-light reviews · Tier 1 + Tier 2 sources · audit log export · billed monthly |
| Pro | $99 a month | Full PRISMA 2020 synthesis · risk-of-bias tools · living synthesis · scoping reviews · peer-review workflow · billed monthly |
| Team | $399 a month | Up to 5 users · shared workspace · role-based access · team-wide audit trail · billed monthly |
| Business | $1,499 a month | Coming soon · up to 20 users · SSO · advanced audit and compliance reporting · billed monthly |
| Enterprise | Priced on request | Coming soon · custom source integrations · on-premise / VPC deployment · Canadian data residency |
The facts
Each one read from Embarke's own pages, with the date it was checked.
What it does
- Certainty estimates
- The Calibrator estimates certainty per finding using GRADE domains, and labels the ratings machine-estimated for human review.checked 8 Oct 2026
- Integrations
- The methodology page says cited DOI metadata is enriched through Crossref and Retraction Watch.checked 8 Oct 2026
- Living synthesis
- Saved projects can be scheduled for daily, weekly, or monthly reruns that report citation and retraction-status changes.checked 8 Oct 2026
- LLM usage
- The pricing page says LLM usage is included in paid plans, subject to fair-use quotas per tier.checked 8 Oct 2026
- Methodology limitation
- Embarke says its PRISMA-aligned synthesis is AI-assisted and does not provide prospective protocol registration or independent dual screening.checked 8 Oct 2026
- Pricing availability
- The pricing page calls pricing a preview and says self-serve checkout is not active yet; it directs users to contact Embarke for early access.checked 8 Oct 2026
- PRISMA outputs
- Its PRISMA 2020-aligned runs generate a structured report and an automatically generated flow diagram.checked 8 Oct 2026
- Reproducibility
- Reports can be exported with a ZIP containing report files, source and model details, prompt hashes, citation exports, and a SHA-256 manifest signature.checked 8 Oct 2026
- Retraction checks
- Embarke enriches cited DOIs using Crossref and Retraction Watch, and flags retracted papers or expressions of concern in reports.checked 8 Oct 2026
- Risk-of-bias tools
- The methodology page lists RoB 2, ROBINS-I, AMSTAR 2, and QUADAS-2, with reviewers able to override proposed domain judgments.checked 8 Oct 2026
- Self-hosting
- The regulatory page says the open-source stack supports deployment on the customer’s own Kubernetes infrastructure.checked 8 Oct 2026
- What it does
- Embarke produces audit-oriented research syntheses for medical writers, regulatory teams, and health technology assessment professionals.checked 8 Oct 2026
Alternatives to Embarke
- 1
Perplexity
Free planAndroidiOSWebAPI8.2From $20 a month - 2
Consensus
Free planAndroidiOSWebAPI8.1From $20 a month - 3
Liner
Free planAndroidiOSWebAPI8.1From $14.99 a month - 4
SciSpace
Free planAndroidiOSWebAPI8.1From $96 a year - 5
Gab AI Research Assistant
Free planAndroidiOSWebAPI8.0From $16.67 a month - 6
Fabric
AndroidiOSWebAPI7.9From $8 a month